Botanical clinical trials could be conducted by herbal experts -- FDA's Temple.
This article was originally published in The Tan Sheet
Executive Summary
BOTANICAL TRIALS CONDUCTED BY HERBALISTS WOULD BE ACCEPTABLE TO FDA, Robert Temple, MD, director of FDA's Office of Drug Evaluation I, said at the Drug Information Association's annual meeting June 9-13 in San Diego. "We don't have a rule that people who carry out trials have to be...physicians," Temple said. Although there is "some obligation to make sure there's a medical person around to worry about risk," he added, "I don't see why someone with [an herbal] background couldn't carry out the trial."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning